BriaCell Therapeutics Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCT.TO | HBP.TO | 6OP.F | HURA | CHRS | BOLT | |
|---|---|---|---|---|---|---|
| Market cap | 38.86M | 70.27M | 42.99M | 109.61M | 131.36M | 15.42M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.2 | -8.4 | — | -2.8 | -1.3 | -0.3 |
| Price/book | 1.7 | 4.8 | 1.4 | 6.0 | 2.2 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −68.17% | −54.68% | −66.91% | −29.80% | −42.95% | +34.91% |
| Today | +5.95% | 0.00% | −2.85% | +3.93% | +5.54% | −0.46% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCT.TO news ›BriaCell Therapeutics (TSE:BCT) Stock Price Down 9% – What’s Next?
Posted by Tristan Rich on Oct 18th, 2026 BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report) fell 9% during trading on Friday. The stock traded as low as C$4.80 and last traded at C$4.88. Approximately 15,457 shares were traded during…
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Briacell therapeutics corp. a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. today announced that four abstracts featuring…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- investingnews.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.